Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CANTEL MEDICAL LLC (CMD)
|
Add to portfolio |
|
|
|
| Price: |
$84.97
| | Metrics |
| OS: |
42.3
|
M
| |
7
|
% ROE
|
| Market cap: |
$3.6
|
B
| |
19
|
% ROIC
|
|
Net debt:
|
$673
|
M
| |
2.7
|
x Debt/EBITDA
|
|
EV:
|
$4.27
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$246
|
M
| |
17.4
|
x EV/EBITDA
|
|
EBIT
|
$135
|
M
| |
31.7
|
x EV/EBIT
|
| EPS |
$1.26
| |
67.2
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jul-31-19 | Jul-05-19 | Jul-31-18 | Jul-31-17 | Jul-31-16 | Jul-31-15 | Jul-31-14 | Jul-31-13 |
| Revenues | 918.2 | 918.2 | 871.9 | 770.2 | 664.8 | 565.0 | 488.7 | 425.0 |
| Revenue growth | 5.3% | | 13.2% | 15.9% | 17.7% | 15.6% | 15.0% | 10.0% |
| Cost of goods sold | 490.7 | 490.7 | 458.0 | 403.0 | 355.6 | 311.5 | 275.5 | 241.6 |
| Gross profit | 427.5 | 427.5 | 414.0 | 367.2 | 309.2 | 253.5 | 213.3 | 183.5 |
| Gross margin | 46.6% | 46.6% | 47.5% | 47.7% | 46.5% | 44.9% | 43.6% | 43.2% |
| Sales and marketing | 140.2 | 140.2 | 129.6 | 116.1 | 99.1 | 80.8 | 66.5 | 57.8 |
| Research and development | 31.3 | 31.3 | 24.6 | 18.4 | 15.4 | 14.0 | 10.8 | 9.3 |
| General and administrative | 172.4 | 172.4 | 138.0 | 122.3 | 97.5 | 77.9 | 65.0 | 53.2 |
| EBITA | 104.4 | 104.4 | 139.0 | 128.8 | 111.0 | 98.8 | 81.4 | 75.7 |
| EBITA margin | 11.4% | 11.4% | 15.9% | 16.7% | 16.7% | 17.5% | 16.6% | 17.8% |
| Amortization of intangibles | 20.8 | 20.8 | 17.4 | 18.4 | 13.1 | 13.3 | 10.6 | 10.1 |
| EBIT | 83.5 | 83.5 | 121.7 | 110.4 | 97.9 | 85.6 | 70.7 | 65.7 |
| EBIT margin | 9.1% | 9.1% | 14.0% | 14.3% | 14.7% | 15.1% | 14.5% | 15.5% |
| Pre-tax income | 75.3 | 75.3 | 117.5 | 106.2 | 93.9 | 76.2 | 68.6 | 60.4 |
| Income taxes | 20.3 | 20.3 | 26.5 | 34.9 | 34.0 | 28.2 | 25.3 | 21.1 |
| Tax rate | 26.9% | 26.9% | 22.5% | 32.8% | 36.2% | 37.1% | 36.9% | 35.0% |
| Net income | 55.0 | 55.0 | 91.0 | 71.4 | 60.0 | 48.0 | 43.3 | 39.2 |
| Net margin | 6.0% | 6.0% | 10.4% | 9.3% | 9.0% | 8.5% | 8.9% | 9.2% |
| |
| Diluted EPS | $1.32 | $1.32 | $2.19 | $1.72 | $1.45 | $1.16 | $1.06 | $0.97 |
| Shares outstanding (diluted) | 41.8 | 41.8 | 41.6 | 41.5 | 41.4 | 41.2 | 40.9 | 40.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|